These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6158923)

  • 21. Inosiplex: an immunomodulation model for the treatment of viral disease.
    Ginsberg T; Glasky AJ
    Ann N Y Acad Sci; 1977 Mar; 284():128-38. PubMed ID: 81634
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro studies on cell-mediated immunity in patients treated with inosiplex for herpes virus infection.
    Bradshaw LJ; Sumner HL
    Ann N Y Acad Sci; 1977 Mar; 284():190-6. PubMed ID: 81637
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of inosiplex on host defense against infections (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Shimada S; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Jul; 55(7):479-89. PubMed ID: 6173449
    [No Abstract]   [Full Text] [Related]  

  • 24. [Protective effects of inosiplex in viral infections. Comparison with other immunostimulants (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Okura M; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Aug; 55(8):551-7. PubMed ID: 6173452
    [No Abstract]   [Full Text] [Related]  

  • 25. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levamisole and inosiplex: antiviral agents with immunopotentiating action.
    Hadden JW; Lopez C; O'Reilly RJ; Hadden EM
    Ann N Y Acad Sci; 1977 Mar; 284():139-52. PubMed ID: 81635
    [No Abstract]   [Full Text] [Related]  

  • 27. Toxicity of nickel for mammalian cells in culture.
    Skreb Y; Fischer AB
    Zentralbl Bakteriol Mikrobiol Hyg B; 1984 Jan; 178(5-6):432-45. PubMed ID: 6720141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inosiplex: a novel treatment in rheumatoid arthritis?
    Wybran J; Famaey JP; Appelboom T
    J Rheumatol; 1981; 8(4):643-6. PubMed ID: 6170755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro studies on the influence of volatile anaesthetics on cell number, cell volume, and cellular protein, DNA, and RNA content (author's transl)].
    Hack G; Karzel K; Panthong A; Stein P
    Anaesthesist; 1981 Mar; 30(3):134-43. PubMed ID: 7224142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences.
    Winn SR; Lindner MD; Lee A; Haggett G; Francis JM; Emerich DF
    Exp Neurol; 1996 Aug; 140(2):126-38. PubMed ID: 8690056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic treatment of mollusca contagiosa with inosiplex.
    Gross G; Jogerst C; Schöpf E
    Acta Derm Venereol; 1986; 66(1):76-80. PubMed ID: 2424225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effects of two immunopotentiators, Isoprinosine and NPT 15392, on murine T-cell differentiation and function.
    Ikehara S; Hadden JW; Good RA; Lunzer DG; Pahwa RN
    Thymus; 1981 Aug; 3(2):87-95. PubMed ID: 6170135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isoprinosine: effect and dose].
    Saurat JH
    Ann Dermatol Venereol; 1984; 111(1):71. PubMed ID: 6203461
    [No Abstract]   [Full Text] [Related]  

  • 34. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunostimulative therapy of herpes zoster (three years' experience with inosiplex) (author's transl)].
    Bunta S; Peris Z
    Z Hautkr; 1981 Nov; 56(22):1457-66. PubMed ID: 6171939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoprinosine increases the antitumor action of interferon.
    Cerutti I; Chany C; Schlumberger JF
    Cancer Treat Rep; 1978 Nov; 62(11):1971-4. PubMed ID: 83190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Goat serum: an alternative to fetal bovine serum in biomedical research.
    Paranjape S
    Indian J Exp Biol; 2004 Jan; 42(1):26-35. PubMed ID: 15274477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection.
    Waldman RH; Ganguly R
    Ann N Y Acad Sci; 1977 Mar; 284():153-60. PubMed ID: 81636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.